1. Home
  2. PTY vs AMRX Comparison

PTY vs AMRX Comparison

Compare PTY & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTY
  • AMRX
  • Stock Information
  • Founded
  • PTY 2002
  • AMRX 2002
  • Country
  • PTY United States
  • AMRX United States
  • Employees
  • PTY N/A
  • AMRX N/A
  • Industry
  • PTY Investment Managers
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTY Finance
  • AMRX Health Care
  • Exchange
  • PTY Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • PTY 2.2B
  • AMRX 2.6B
  • IPO Year
  • PTY N/A
  • AMRX N/A
  • Fundamental
  • Price
  • PTY $14.49
  • AMRX $8.56
  • Analyst Decision
  • PTY
  • AMRX Strong Buy
  • Analyst Count
  • PTY 0
  • AMRX 5
  • Target Price
  • PTY N/A
  • AMRX $10.00
  • AVG Volume (30 Days)
  • PTY 550.4K
  • AMRX 1.0M
  • Earning Date
  • PTY 01-01-0001
  • AMRX 02-28-2025
  • Dividend Yield
  • PTY 9.65%
  • AMRX N/A
  • EPS Growth
  • PTY N/A
  • AMRX N/A
  • EPS
  • PTY N/A
  • AMRX N/A
  • Revenue
  • PTY N/A
  • AMRX $2,680,420,000.00
  • Revenue This Year
  • PTY N/A
  • AMRX $17.86
  • Revenue Next Year
  • PTY N/A
  • AMRX $3.90
  • P/E Ratio
  • PTY N/A
  • AMRX N/A
  • Revenue Growth
  • PTY N/A
  • AMRX 12.32
  • 52 Week Low
  • PTY $11.92
  • AMRX $5.01
  • 52 Week High
  • PTY $14.88
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • PTY 56.06
  • AMRX 63.41
  • Support Level
  • PTY $14.35
  • AMRX $7.63
  • Resistance Level
  • PTY $14.45
  • AMRX $8.42
  • Average True Range (ATR)
  • PTY 0.09
  • AMRX 0.26
  • MACD
  • PTY 0.02
  • AMRX 0.09
  • Stochastic Oscillator
  • PTY 97.27
  • AMRX 96.89

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: